JP2025513894A5 - - Google Patents
Info
- Publication number
- JP2025513894A5 JP2025513894A5 JP2024560753A JP2024560753A JP2025513894A5 JP 2025513894 A5 JP2025513894 A5 JP 2025513894A5 JP 2024560753 A JP2024560753 A JP 2024560753A JP 2024560753 A JP2024560753 A JP 2024560753A JP 2025513894 A5 JP2025513894 A5 JP 2025513894A5
- Authority
- JP
- Japan
- Prior art keywords
- tapi
- cell
- polynucleotide
- cancer
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263331773P | 2022-04-15 | 2022-04-15 | |
| US63/331,773 | 2022-04-15 | ||
| PCT/US2023/065784 WO2023201340A2 (en) | 2022-04-15 | 2023-04-14 | Compositions and methods for reducing cell therapy immunogenicity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513894A JP2025513894A (ja) | 2025-04-30 |
| JP2025513894A5 true JP2025513894A5 (https=) | 2026-04-22 |
Family
ID=88330399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560753A Pending JP2025513894A (ja) | 2022-04-15 | 2023-04-14 | 細胞療法の免疫原性を低下させるための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250325585A1 (https=) |
| EP (1) | EP4508197A2 (https=) |
| JP (1) | JP2025513894A (https=) |
| AU (1) | AU2023254114A1 (https=) |
| CA (1) | CA3249063A1 (https=) |
| WO (1) | WO2023201340A2 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6681837B2 (ja) * | 2014-03-11 | 2020-04-15 | セレクティスＣｅｌｌｅｃｔｉｓ | 同種移植に適合するｔ細胞を作製するための方法 |
| JP7384896B2 (ja) * | 2018-07-22 | 2023-11-21 | ヘルス リサーチ インコーポレイテッド | 主要組織適合遺伝子複合（ｍｈｃ）クラスｉｉ－発現癌細胞ワクチン、及び統合免疫応答を生じさせるための使用方法 |
-
2023
- 2023-04-14 EP EP23789180.9A patent/EP4508197A2/en active Pending
- 2023-04-14 AU AU2023254114A patent/AU2023254114A1/en active Pending
- 2023-04-14 JP JP2024560753A patent/JP2025513894A/ja active Pending
- 2023-04-14 US US18/856,592 patent/US20250325585A1/en active Pending
- 2023-04-14 WO PCT/US2023/065784 patent/WO2023201340A2/en not_active Ceased
- 2023-04-14 CA CA3249063A patent/CA3249063A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109485734B (zh) | 一种靶向bcma和cd19的双特异性嵌合抗原受体及其应用 | |
| JP2021000103A5 (https=) | ||
| AU2023201162A1 (en) | Compositions and methods for immunooncology | |
| RU2017105160A (ru) | Лечение рака с помощью химерного антигенного рецептора к cd33 | |
| JP2018527014A5 (https=) | ||
| RU2017108903A (ru) | Химерный антигенный рецептор (car) против cd123 для использования в лечении злокачественных опухолей | |
| JP2019515661A5 (https=) | ||
| EP4104187A1 (en) | Method of predicting response to chimeric antigen receptor therapy | |
| JP2017522879A5 (https=) | ||
| JP2017527271A5 (https=) | ||
| RU2017105161A (ru) | Лечение рака с использованием химерного антигенного рецептора cll-1 | |
| JP2017524367A5 (https=) | ||
| JP2022512882A5 (https=) | ||
| JP2017530694A5 (https=) | ||
| US11401317B2 (en) | Human-CD123-targeting chimeric receptor ligand and application thereof | |
| JP2021530233A5 (https=) | ||
| EP4055049A1 (en) | Bcma-targeted car-t cell therapy of multiple myeloma | |
| JP2022530773A5 (https=) | ||
| JP2024525609A5 (https=) | ||
| JP2023518930A5 (https=) | ||
| JP2020500903A5 (https=) | ||
| CN118221828B (zh) | Car分子、car细胞和car药物组合物及其应用 | |
| JP2025513894A5 (https=) | ||
| US20230399627A1 (en) | Vector genetically engineered with chimeric antigen receptor and against two or more targets and application thereof | |
| IL303060A (en) | Chimeric receptors and methods of their use |